Early trial aims to tame Diabetes-Like condition in CF patients
NCT ID NCT06995651
Summary
This early-stage study is testing a drug called dorzagliatin to see if it helps control blood sugar in adults with cystic fibrosis (CF) who also have pancreatic problems. Researchers will compare the drug to a placebo (inactive pill) in 15 participants to measure how the body processes the drug and if it improves how the body handles sugar after a meal. The goal is to see if this treatment could help manage a common diabetes-like complication of CF.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS-RELATED DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital of University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
University of Pennsylvania Center for Human Phenomic Science (CHPS)
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.